↑
Skip links

Proven performance of domestic AI low-dose CT technology

2022-09-21

Proven performance of domestic AI low-dose CT technology

【Welfare News】 The artificial intelligence low-dose CT technology developed in Korea is attracting attention as its performance has been proven in multinational clinical trials for the first time.

×

New Partnerships at ClariPi

Nov 22, 2022

ClariPi Joins Siemens Healthineers Digital Marketplace

https://www.prnewswire.com/news-releases/claripi-joins-siemens-healthineers-digital-marketplace-301685732.html?tc=eml_cleartime

https://marketplace.teamplay.siemens-healthineers.com/apps

ClariPi’s breast density measurement solution, ClariSIGMAM, Joins Bayer’s Calantic Digital Solutions

https://www.bayer.com/media/en-us/bayer-advances-radiology-development-portfolio-and-fosters-innovation-in-ai/

Contact Us

ClariPi will be at KIMES 2023 (Hall D 316)

Mar 23, 2023 - Mar 26, 2023
Seoul COEX, South Korea

Booth: Hall D 316

If you are interested in our products, you could visit our booth or arrange a demo session online. Just message us to schedule a meeting! Thank you!

Our Presentation Schedule:

Time: Thursday, March 23: 10:30 – 10:50

Speaker: Prof. Jong Hyo Kim, CEO ClariPi

Location: Seoul COEX, Conference Room 308

Topic: Preoccupying Global Issues in Medical Imaging AI Devices: Trustworthy AI Guaranteed Leading Model

Click Here to find out more! Request A Meeting